Athanor Capital’s CVS Health CVS Stock Holding History

Athanor Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,100	Closed	-$899K	–	200
2019 Q4	$899K	Buy	+12,100	New	+$850K	0.04%	166

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Athanor Capital's CVS Position: Q1 2020 in Review

Athanor Capital sold out of CVS Health (CVS) in Q1 2020, closing a stake of 12,100 shares — an estimated $899K sold.

Athanor Capital first reported a position in CVS in Q4 2019 and held it in 1 quarter. The position peaked at $899K in Q4 2019. 1,818 funds tracked by Wall St. Rank hold CVS as of Q1 2020.

Athanor Capital reported no remaining CVS Health position as of Q1 2020 after selling out during the quarter.
Athanor Capital sold 12,100 CVS Health shares in Q1 2020, an estimated $899K.
Athanor Capital first reported a position in CVS Health in Q4 2019 and held it in 1 quarter.
Athanor Capital's CVS Health position peaked at $899K in Q4 2019.
1,818 funds tracked by Wall St. Rank held CVS Health as of Q1 2020.

Based on Athanor Capital's 13F filing for Q1 2020, filed 14 May 2020.